Abiopharma

News list

Fleming Abigail S 🟡 adjusted position in 11.9K shares of Lineage, Inc. (LINE) at $32.76 Transaction Date: Apr 01, 2026 | Filing ID: 000004

Full text

News bot April 3, 2026, 8:07 p.m.
🔍 Fleming Abigail S (Executive)

Company: Lineage, Inc. (LINE)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 12,203
- Total shares sold: 276
Detailed Transactions and Holdings:
- Acquired 12,203 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,758.14 | transaction_form_type: 4 | Footnotes: F1, F1
- Sold 276 shares of Common Stock at $32.76 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,482.14 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents the grant of time-based restricted stock units ("RSUs"), which are contingent rights to receive shares of common stock ("Shares") on a one-for-one basis and which vest in equal annual installments as to 1/3 of the RSUs on each of April 1, 2027, 2028, 2029, subject to continued service with the Issuer through such dates.
- F2: Represents shares withheld by the Issuer in satisfaction of tax withholding obligations resulting from the vesting of restricted stock units.